PARIS, May 18 /PRNewswire/ -- The Institut Pasteur and Merieux Alliance have signed a letter of intent for a long-term research partnership.
The Institut Pasteur and Merieux Alliance (which comprises the companies: bioMerieux, Transgene, Shantha Biotechnics, ABL and Silliker) would like to pool their resources and efforts to fight infectious diseases through major research projects, spanning the following fields:
- Clinical diagnostics and theranostics (in partnership with bioMerieux and Transgene) - Food safety and microbiological control, nutrition, health and environment (with bioMerieux and Silliker) - Immunotherapy (with Transgene and Shantha Biotechnics)
The research projects under consideration must focus on major pathologies calling upon expertise in the fields of virology, bacteriology and immunology. The results of these joint research projects could be utilized by the Merieux Alliance companies and would enhance the Institut Pasteur's patent portfolio, contributing to the valorization of its research efforts.
This collaboration between a world-renowned scientific foundation and a major bioindustrial group exemplifies the cross-disciplinary approach needed to develop new solutions for fighting infectious diseases. It also represents a new and significant milestone in the collaboration between the Institut Pasteur and a group sharing Pasteurian roots, dedicated to biology and serving public health worldwide.
The signature of this letter of intent follows an agreement signed
between the Institut Pasteur and the Fondation Merieux on April 14th, aimed
at encouraging collaboration in the fight against infectious diseases in
developing countries. This includes research to develop solutions adapted to
local constraints, interactions between the international network of Pasteur
institutes and the Fondation Merieux's GABRIEL netwo
|SOURCE The Institut Pasteur and Merieux Alliance|
Copyright©2009 PR Newswire.
All rights reserved